1. Frequency and prognostic impact of periprocedural myocardial infarction determined by various MI definitions in patients with chronic coronary syndromes undergoing percutaneous coronary intervention. (14th October 2021) Authors: Ueki, Y; Otsuka, T; Bar, S; Koskinas, K; Losdat, S; Heg, D; Zanchin, T; Siontis, G; Praz, F; Haner, J; Susuri, N; Stortecky, S; Pilgrim, T; Windecker, S; Raber, L Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of alirocumab added to high-intensity statin therapy on platelet function in AMI patients: a pre-specified substudy of the randomized, placebo-controlled PACMAN-AMI trial. (3rd October 2022) Authors: Ueki, Y; Haner, J; Losdat, S; Gargiulo, G; Bar, S; Otsuka, T; Kavaliauskaite, R; Mitter, V; Temperli, F; Shibutani, H; Siontis, G; Valgimigli, M; Windecker, S; Koskinas, K; Raber, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗